Ridgewood Investments LLC Bristol Myers Squibb CO Call Options Transaction History

Ridgewood Investments LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 04, 2024	SELL	$39.66 - $51.75 $59,489 - $77,625	-1,500 Reduced 30.0%	3,500 $181,000
Q2 2024 Jul 29, 2024	BUY	$40.25 - $52.99 $120,750 - $158,970	3,000 Added 150.0%	5,000 $207,000
Q3 2023 Oct 20, 2023	BUY	$57.89 - $64.73 $115,780 - $129,460	2,000 New	2,000 $116,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ridgewood Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Ridgewood Investments LLC with notifications on news.